Desmedt Stéphanie, Marlier Joke, Van de Velde Frederique, Van Nieuwenhove Yves, Batens Arsene-Helene, Matthys Imke, Lapauw Bruno
Ghent University Hospital, Ghent, Belgium.
Obes Surg. 2025 Jun 6. doi: 10.1007/s11695-025-07929-y.
Precise diagnostics for postprandial reactive hypoglycaemic syndrome (PRHS) after gastric bypass surgery (GBS) are lacking. Oral glucose tolerance tests (OGTT) are advocated but might cause early dumping and lack specificity. This study aims to evaluate glucometabolic responses and symptoms during liquid and solid mixed meal tolerance tests (LMMTT and SMMTT).
Twenty-two subjects at least 1 year after GBS, divided into PRHS and non-PRHS based on clinical assessment and 14 control subjects (6 normal-weight, 8 with obesity) participated. All underwent 3-h LMMTT and SMMTT during which glucometabolic responses as well as hypoglycaemic symptoms using the Edinburgh hypoglycaemia symptom scale (EHSS) were assessed.
During LMMTT, nadir glucose levels nor frequency of levels < 70 mg/dl and < 54 mg/dl did differ between groups. LMMTT could not differentiate between PRHS and non-PRHS in terms of total count of symptoms, and the number of symptoms was not associated with low glycaemia. During SMMTT, glucometabolic responses were similar between PRHS and non-PRHS. However, significantly more hypoglycaemic symptoms were evocated in the group with PRHS compared to those without during the second phase of SMMTT, with more neuroglycopenic and malaise symptoms in the subjects with PRHS. The decrease rate of glucose was higher in subjects with PRHS with malaise symptoms from 105 to 180 min compared to those without malaise.
LMMTT is not able to differentiate hypoglycaemic symptoms and low glycaemic values between subjects with PRHS and subjects without PRHS, whereas SMMTT could be of greater value. The clinical value of set glucose levels and the use of other biochemical parameters used to diagnose PRHS needs to be further evaluated.
胃旁路手术(GBS)后餐后反应性低血糖综合征(PRHS)缺乏精确的诊断方法。口服葡萄糖耐量试验(OGTT)虽被提倡,但可能会引发早期倾倒综合征且缺乏特异性。本研究旨在评估液体和固体混合餐耐量试验(LMMTT和SMMTT)期间的糖代谢反应及症状。
22名GBS术后至少1年的受试者,根据临床评估分为PRHS组和非PRHS组,另有14名对照受试者(6名体重正常,8名肥胖)参与。所有受试者均接受3小时的LMMTT和SMMTT,在此期间评估糖代谢反应以及使用爱丁堡低血糖症状量表(EHSS)评估低血糖症状。
在LMMTT期间,两组之间的最低血糖水平以及血糖水平<70mg/dl和<54mg/dl的频率并无差异。LMMTT在症状总数方面无法区分PRHS和非PRHS,且症状数量与低血糖无关。在SMMTT期间,PRHS组和非PRHS组的糖代谢反应相似。然而,在SMMTT的第二阶段,与无PRHS的组相比,PRHS组诱发的低血糖症状明显更多,PRHS受试者出现更多的神经低血糖症状和不适症状。与无不适症状的受试者相比,有不适症状的PRHS受试者在105至180分钟期间血糖下降速率更高。
LMMTT无法区分PRHS受试者和非PRHS受试者之间的低血糖症状和低血糖值,而SMMTT可能更具价值。设定血糖水平的临床价值以及用于诊断PRHS的其他生化参数的应用需要进一步评估。